COMMUNIQUÉS West-GlobeNewswire

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
01/09/2026
Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to [...]
Kinjirushi Introduces Hexaraphane and Research Into Its Potential Brain Health Benefits to North America
01/09/2026
Japanese wasabi specialist brings decades of expertise to North America as research explores the relationship between wasabi-derived compounds, cognitive function and healthy aging TORRANCE, Calif., Sept. 01, 2026 ( [...]
Sofwave to Participate in the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
SAN CLEMENTE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
01/09/2026
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
Belite Bio to Participate in Four Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09/2026
FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and [...]
Septerna to Participate in Upcoming Investor Conferences
01/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
01/09/2026
New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) ( [...]
Biomerica Reports Fiscal 2026 Year-End Financial Results
01/09/2026
Fiscal 2026 fourth quarter net sales increased approximately 17% compared to the fourth quarter of fiscal 2025 Full-year net loss improved by approximately 24% to approximately $3.8 million InFoods IBS update: 100% of [...]
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
01/09/2026
Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“ [...]
Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI [...]
Conexeu Sciences Sets September and October 2026 Conference Schedule
01/09/2026
RENO, Nev., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, is [...]
Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences
01/09/2026
Company will exhibit at five major conferences this fall, engaging psychiatrists, pediatricians, child and adolescent psychiatrists, and the broader ADHD community Sponsored product theater presentations at US Psych [...]
SAB BIO to Participate in Upcoming Investor Conferences
01/09/2026
MIAMI, Sept. 01, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
01/09/2026
Dr. Charlton brings over 15 years of rare disease and pediatric drug development experience including CMO and clinical development roles Appointment further strengthens clinical leadership and execution capabilities [...]
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
01/09/2026
$5 Million Upfront at Closing and $5 Million Tranche Warrant Callable by the Company Following FDA 510(k) Clearance of Intelligent Fingerprinting Drug Screening System NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- [...]
Celcuity To Participate in Upcoming Investor Conferences
01/09/2026
MINNEAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, [...]
DnaK Therapeutics & GATC Health Forge A Partnership To Evaluate, Accelerate & Prioritize Cancer Drug Candidates Using AI Platform
01/09/2026
The collaboration will utilize predictive artificial intelligence for identifying the most promising molecules from an expansive pipeline that will substantially accelerate proof of concept timelines and markedly reduce [...]

Pages